1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5 GLOBAL L-HISTIDINE MARKET, BY PRODUCT TYPE
5.1 TABLET
5.2 CAPSULE
5.3 FLUIDS
5.4 OTHERS
6. GLOBAL L-HISTIDINE MARKET, BY APPLICATION
6.1 PHARMACEUTICAL INDUSTRY
6.2 BIOTECHNOLOGICAL INDUSTRY
6.3 MEDICAL INDUSTRY
7. GLOBAL L-HISTIDINE MARKET, BY REGION
7.1 INTRODUCTION
7.2 AMERICAS
7.2.1 NORTH AMERICA
7.2.2 SOUTH AMERICA
7.3 EUROPE
7.3.1 GERMANY
7.3.2 FRANCE
7.3.3 ITALY
7.3.4 SPAIN
7.3.5 U.K
7.3.6 REST OF EUROPE
7.4. ASIA-PACIFIC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 REPUBLIC OF KOREA
7.5 MIDDLE EAST & AFRICA
7.5.1 UAE
7.5.2 SAUDI AERBIA
7.5.3 KUWAIT
7.5.4 QATAR
7.5.5 OMAN
7.5.6 REST OF MIDDLE EAST & AFRICA
8. COMPETITIVE LANDSCAPE
8.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
8.1.1 STRATEGIC PARTNERSHIP
8.1.2 MERGER & ACQUISITION
9 COMPANY PROFILE
9.1 ANGENE CHEMICALS
9.1.1 OVERVIEW
9.1.2 PRODUCT OVERVIEW
9.1.3 FINANCIALS
9.1.4 KEY DEVELOPMENTS
9.2 ABI CHEMICALS
9.2.1 OVERVIEW
9.2.2 PRODUCT OVERVIEW
9.2.3 FINANCIALS
9.2.4 KEY DEVELOPMENTS
9.3 ACRON PHARMA
9.3.1 OVERVIEW
9.3.2 PRODUCT OVERVIEW
9.3.3 FINANCIALS
9.3.4 STRATEGY
9.3.5 KEY DEVELOPMENT
9.4 AJIMOMOTO
9.4.1 OVERVIEW
9.4.2 PRODUCT OVERVIEW
9.4.3 FINANCIALS
9.4.4 KEY DEVELOPMENTS
9.5 CHANGZHOU HIGHASSAY CHEMICAL CO. LTD
9.5.1 OVERVIEW
9.5.2 PRODUCT OVERVIEW
9.5.3 FINANCIALS
9.5.4 KEY DEVELOPMENTS
9.6 HUAHENG BIOLOGGICAL
9.6.1 OVERVIEW
9.6.2 PRODUCT OVERVIEW
9.6.3 FINANCIALS
9.6.4 KEY DEVELOPMENTS
9.7 MY PROTEIN
9.7.1 OVERVIEW
9.7.2 PRODUCT OVERVIEW
9.7.3 FINANCIALS
9.7.4 KEY DEVELOPMENTS
9.8 TWIN LABS
9.8.1 OVERVIEW
9.8.2 PRODUCT OVERVIEW
9.8.3 FINANCIALS
9.8.4 KEY DEVELOPMENTS
9.9 OTHERS